Laboratorio Farmaceutico Erfo Spa announced Friday that in the week of May 20-24 it purchased 13,000 ordinary shares at an average price of EUR1.179615 per share, for a total value of EUR15,335.00. .
Laboratorio Farmaceutico Erfo Spa reported Wednesday evening that its board of directors reviewed some consolidated economic and financial operating data as of March 31, 2024, reporting revenues of.
ITALY GROWTH WINNERS & LOSERS: Erfo and iVision Tech lead the risers marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Laboratorio Farmaceutico Erfo Spa reported that it closed 2023 with a net profit of EUR600,000, broadly in line with the EUR700,000 profit recorded in 2022. Consolidated group revenues as of December.
On Monday, major European stock markets open the day in the red meeting forecasts, on a quiet day from the perspective of macro economic data and corporate results, with the Canadian and American.